Jim Cramer Says He Blessed MannKind as a Speculation Only
Key takeaways
- Answering a caller’s query about the stock during the lightning round, Cramer stated:
- In my book, I talk about how you can have one speculation, and then you have to have other stocks that are, you know, considered to be a little bit more earnings-oriented.
- While we acknowledge the potential of MNKD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk.
Jim Cramer Says He Blessed Mann Kind as a Speculation Only Syeda Seirut Javed Mon, June 8, 2026 at 10:34 PM GMT+7 1 min read MNKD Mann Kind Corporation (NASDAQ:MNKD) was among the stocks Jim Cramer highlighted on Mad Money as he noted that the market has an appetite for stocks. Answering a caller’s query about the stock during the lightning round, Cramer stated:
100% speculation, a total speculation. In my book, I talk about how you can have one speculation, and then you have to have other stocks that are, you know, considered to be a little bit more earnings-oriented. This would fit as that speculation, so I blessed it for that purpose only.
MannKind Corporation (NASDAQ:MNKD) is a biopharmaceutical company that develops and commercializes inhaled therapies, wearable delivery devices, and injectable treatments to manage chronic conditions like diabetes, pulmonary hypertension, and fluid overload.